Gilead Sciences, Inc.
Therapeutic compositions for treatment of human immunodeficiency virus

Abstract:

A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.